Current update on the protective effect of naringin in inflammatory lung diseases

Authors

  • Gaurav Gupta School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Mahal Road, Jaipur, India. E-mail: gauravpharma25@gmail.com https://orcid.org/0000-0001-7941-0229
  • Waleed Hassan Almalki Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia https://orcid.org/0000-0003-2584-8510
  • Imran Kazmi Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia https://orcid.org/0000-0002-6272-1976
  • Neeraj Kumar Fuloria Faculty of Pharmacy, AIMST University, Bedong 08100, Kedah, Malaysia https://orcid.org/0000-0002-8970-5212
  • Shivkanya Fuloria Faculty of Pharmacy, AIMST University, Bedong 08100, Kedah, Malaysia https://orcid.org/0000-0002-5381-5655
  • Vetriselvan Subramaniyan Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jalan SP 2, Bandar Saujana Putra, 42610 Jenjarom Selangor, Malaysia https://orcid.org/0000-0002-3488-7311
  • Mahendran Sekar Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh 30450, Perak, Malaysia https://orcid.org/0000-0002-3022-6137
  • Sachin Kumar Singh School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Faculty of Health, Australian Research Center in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, Australia https://orcid.org/0000-0003-4579-3262
  • Dinesh Kumar Chellappan Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia https://orcid.org/0000-0002-0013-8662
  • Kamal Dua Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Center in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, Australia https://orcid.org/0000-0002-7507-1159

DOI:

https://doi.org/10.17179/excli2022-4752

Keywords:

inflammatory lung diseases, naringin, COPD, lung cancer

Published

2022-03-07

How to Cite

Gupta, G., Almalki, W. H., Kazmi, I., Fuloria, N. K., Fuloria, S., Subramaniyan, V., Sekar, M., Singh, S. K., Chellappan, D. K., & Dua, K. (2022). Current update on the protective effect of naringin in inflammatory lung diseases. EXCLI Journal, 21, 573–579. https://doi.org/10.17179/excli2022-4752

Issue

Section

Letters to the editor

Categories

Most read articles by the same author(s)

1 2 > >>